Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD
In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…
In the Clinic Episode 59: Weight Loss
BS Medicine Episode #621: Whole-Body MRI for Cancer Screening: Many findings, little benefit
BS Medicine Episode #620: Back on the stand: Colchicine for secondary cardiovascular prevention update
Presenter(s):
Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD








Please provide any additional comments (optional).